---
figid: PMC9475360__jcav13p3209g001
pmcid: PMC9475360
image_filename: jcav13p3209g001.jpg
figure_link: /pmc/articles/PMC9475360/figure/F1/
number: Figure 1
figure_title: ''
caption: KRAS pathway and its targeted inhibitors. EGFR transmits signals to KRAS
  and activates KRAS; GRB2 promotes the activation of KRAS; and SHP2 is a scaffold
  protein that connects KRAS, GRB2 and SOS1. The red text represents the targeted
  inhibitor for this target.
article_title: KRAS as a Key Oncogene in the Clinical Precision Diagnosis and Treatment
  of Pancreatic Cancer.
citation: Manxiong Dai, et al. J Cancer. 2022;13(11):3209-3220.
year: '2022'

doi: 10.7150/jca.76695
journal_title: Journal of Cancer
journal_nlm_ta: J Cancer
publisher_name: Ivyspring International Publisher

keywords:
- Pancreatic neoplasms
- KRAS gene
- Targeted therapy
- Diagnosis
- Review

---
